Acquisition further advances global leadership position in infection prevention through entry into healthcare information analytics market.
CANTEL MEDICAL CORP. (NYSE:CMD) announced today that it has completed its previously announced acquisition of BHT Hygienetechnik Holding GmbH (“BHT Group”).
Acquisition of global endoscope storage and transport manufacturer further expands Cantel Medical's endoscopy infection prevention & control portfolio
LITTLE FALLS, N.J., Nov. 4, 2014 - CANTEL MEDICAL CORP. (NYSE: CMN) today announced that it acquired International Medical Service S.r.l, or IMS, for a purchase price of €19.6 million in cash consideration. Located in Pomezia, Italy, IMS is a leading manufacturer of high-level disinfectant chemistries used in automated endoscope reprocessors (AERs) as well as other infection prevention and control chemistries used in healthcare and dental markets. In addition, IMS is a manufacturer of high-quality AERs and holds leading share in the Italian AER market. IMS has an employee base of approximately 60 individuals including a complete sales and service team for the Italian market as well as a robust engineering group.
July 1st, 2014 - CANTEL MEDICAL CORP. (NYSE:CMN), today announced that the company has successfully completed the acquisition of PuriCore International Limited., a wholly-owned subsidiary of PuriCore plc (LSE:PURI).
The transaction further enhances Cantel Medical's global leadership of automated endoscope reprocessing and provides the company with additional resources and capabilities to execute on its broader international strategy. PuriCore International Limited will be renamed Cantel Medical (UK) Limited and will be reported as part of our Endoscopy segment.